Molecular techniques were used to characterize genetic features of Staphylococcus aureus in 66 fatal cases of pneumonia caused by S. aureus and influenza A or B viruses. Nucleic acids were extracted from formalin-fixed, paraffin-embedded tissues. The majority of cases revealed genetic markers for Panton-Valentine leukocidin, mecA, and spa type t008.
P
rimary staphylococcal pneumonia occurs predominantly among hospitalized patients, particularly among those who are very young or very old (1) . Bacterial coinfections, notably those caused by Staphylococcus aureus, are identified increasingly as important contributors to fatal pneumonias during influenza pandemics (2) (3) (4) (5) (6) , and animal models of staphylococcal pneumonia suggest that S. aureus infections following influenza virus infections result in increased mortality (7) (8) (9) . However, few studies examining community-acquired staphylococcal pneumonia have thoroughly evaluated for influenza virus coinfections (4, 10, 11) .
The Infectious Diseases Pathology Branch of the Centers for Disease Control and Prevention (CDC) routinely receives autopsy tissues for diagnostic evaluation. In the course of these evaluations, formalin-fixed, paraffin-embedded (FFPE) tissues with histologic evidence of bronchopneumonia and Gram-positive coccoid bacteria in inflammatory infiltrates were subsequently tested for staphylococcal pneumonia using an immunohistochemical (IHC) assay for S. aureus (12) (13) (14) . During 2002 to 2013, 103 cases of IHC-confirmed staphylococcal pneumonia were identified in patients from the United States. Of these, 66 (64%) demonstrated molecular evidence of a coinfection with an influenza A or B virus. No bacterial isolates or corresponding antibiograms were available for evaluation. The patients ranged in age from 7 months to 98 years (median, 18 years). The duration of illness was reported for 76% of patients, and approximately two-thirds died within the first 5 days of illness. Among the 53 case patients for whom data were available, 25 (47%) were hospitalized; 14 (50%) of the 28 case patients who were not hospitalized died in the emergency department.
Molecular testing for influenza viruses demonstrated 20 coinfections with 2009 pandemic H1N1, 6 with seasonal influenza A virus (H1), 9 with seasonal influenza A virus (H3), 3 with unsubtypeable influenza A virus, and 19 with influenza B virus (Tables 1  and 2 ). Seven cases that tested negative for influenza viruses by molecular evaluation of FFPE tissues had other confirmatory results from laboratory testing outside the CDC (3 with 2009 pandemic H1N1, 3 with unsubtypeable influenza A virus, and 1 with influenza B virus). In 2 additional cases, RNA from FFPE respiratory tissues was demonstrated to be of poor quality (15) , although confirmatory laboratory testing done outside the CDC was positive for influenza B virus.
DNA extracted from FFPE lung and airway tissues (see Materials and Methods in the supplemental material) from 51 (77%) of the 66 cases produced analyzable S. aureus protein A (spa) gene amplicons (Table 1) ; in one case, two spa amplicons were obtained, indicating a mixed S. aureus infection. Of these, 43 (84%) of the spa types correlated with multilocus sequence type clonal complex 8, including two novel spa sequences not previously identified in the Ridom database (http://spaserver.ridom.de/). All but one of these 43 cases were positive for Panton-Valentine leukocidin (PVL) toxin and were inferred to be USA300. Of these cases, 33 (65%) were methicillin resistant (mecA positive) ( Tables  1 and 2) . No statistically significant differences in the occurrence of methicillin-resistant S. aureus (MRSA) were found between children (Յ17 years old) or adults or between a duration of illness of Յ5 days or Ͼ5 days. Similarly, no difference in the occurrence of PVL was found between children and adults. Of the 62 cases with histologic evidence of necrotizing pneumonia, 56 (90%) were PVL positive.
To our knowledge, this is the first study to use molecular techniques to characterize strain types, mecA, PVL, and influenza status in FFPE tissues obtained at autopsy from patients with fatal S. aureus pneumonia. In the United States, community-associated MRSA infections, including those resulting in pneumonia, are most frequently caused by isolates of the USA300 pulsed-field type and are usually PVL positive (16, 17) . We identified 45 mecApositive, PVL-positive cases, representing 68% of the analyzed fatal cases with an influenza virus coinfection. This percentage is similar to previous reports that identified PVL in 85 to 97% of patients with necrotizing or fatal staphylococcal pneumonia (18, 19) . While PVL is less common among strains of S. aureus that result in nonfatal pneumonia (20) (21) (22) , our study found it in a large portion of fatal cases and in almost all fatal MRSA cases. Increasing resistance to methicillin has been identified recently among community-acquired S. aureus strains in circulation in the United States (23) (24) (25) , and mecA was also found in the majority of coinfections evaluated in this series.
The expression of virulence factors, including PVL, may be responsible for enhanced virulence (26) , and PVL was identified in the majority of cases in this series; however, it is likely that multiple other characteristics, particularly factors specific to the host, influence the severity of disease (27, 28) . The results of this study further demonstrate the important role of S. aureus as a life-threatening respiratory pathogen, particularly in the context of a concurrent or antecedent influenza virus infection. Of 421 IHC-or PCR-positive influenza cases identified by our group since 2003, 121 (28.7%) had a bacterial coinfection and 66 (54.5%) of the coinfecting bacterial species were identified as S.
aureus. The synergistic effects of influenza and other respiratory viruses with staphylococcal pneumonia are well recognized (4, 29, 30) ; however, the pathogenesis of this interaction is incompletely understood. Influenza viruses target and destroy ciliated epithelial cells that line airways, as well as mucous gland epithelium, resulting in a markedly diminished mucociliary clearance of bacteria that might otherwise be expelled from a normally functioning lung (13) .
Our study was limited to the evaluation of FFPE tissues selected for submission to the CDC. By using real-time PCR, we minimized false-negative results by targeting smaller amplicons that would likely be less fragmented during formalin fixation; nonetheless, it is possible that the frequencies of PVL and mecA could be higher, and fragmentation may explain the number of specimens for which a spa type could not be obtained or for which influenza virus RNA was not detected. Previous studies using the influenza virus reverse transcriptase PCR (RT-PCR) assay suggest that the likelihood of detection is not dependent on the duration of illness (14, 31) ; however, other factors, such as marked tissue necrosis resulting from S. aureus infection, identified in 94% of the cases, could have hampered our ability to detect viral RNA, and the number of influenza virus coinfections could be higher than we detected. The level of community-acquired staphylococcal pneumonias acquired independently of influenza virus coinfections is not well defined, and studies that determine the frequency and pathogenesis of these coinfections are needed. 
